These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 30132373)
1. Discovery of new chromen-4-one derivatives as telomerase inhibitors through regulating expression of dyskerin. Quan Wang J; Di Yang M; Chen X; Wang Y; Zeng Chen L; Cheng X; Hua Liu X J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1199-1211. PubMed ID: 30132373 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety. Han X; Yu YL; Ma D; Zhang ZY; Liu XH J Enzyme Inhib Med Chem; 2021 Dec; 36(1):344-360. PubMed ID: 33356666 [TBL] [Abstract][Full Text] [Related]
3. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity. Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells. Amin KM; Abou-Seri SM; Awadallah FM; Eissa AA; Hassan GS; Abdulla MM Eur J Med Chem; 2015 Jan; 90():221-31. PubMed ID: 25461322 [TBL] [Abstract][Full Text] [Related]
6. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects. Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent. Sun J; Zhu H; Yang ZM; Zhu HL Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864 [TBL] [Abstract][Full Text] [Related]
8. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656 [TBL] [Abstract][Full Text] [Related]
9. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo. Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364 [TBL] [Abstract][Full Text] [Related]
10. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro. Chen X; Zha GF; Wang JQ; Liu XH J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Enantiomeric Separation of a Novel Spiroketal Derivative: A Potent Human Telomerase Inhibitor with High in Vitro Anticancer Activity. Fuggetta MP; De Mico A; Cottarelli A; Morelli F; Zonfrillo M; Ulgheri F; Peluso P; Mannu A; Deligia F; Marchetti M; Roviello G; Reyes Romero A; Dömling A; Spanu P J Med Chem; 2016 Oct; 59(19):9140-9149. PubMed ID: 27592503 [TBL] [Abstract][Full Text] [Related]
13. Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment. Armando RG; Mengual Gómez DL; Juritz EI; Lorenzano Menna P; Gomez DE Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340325 [TBL] [Abstract][Full Text] [Related]
14. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology. Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of celastrol derivatives as anticancer agents. Tang WJ; Wang J; Tong X; Shi JB; Liu XH; Li J Eur J Med Chem; 2015 May; 95():166-73. PubMed ID: 25812966 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, crystal structure and biological evaluation of a new dasatinib copper(II) complex as telomerase inhibitor. Qin QP; Meng T; Tan MX; Liu YC; Luo XJ; Zou BQ; Liang H Eur J Med Chem; 2018 Jan; 143():1597-1603. PubMed ID: 29133054 [TBL] [Abstract][Full Text] [Related]
17. Shikonin N-benzyl matrinic acid ester derivatives as novel telomerase inhibitors with potent activity against lung cancer cell lines. Han H; He C; Chen X; Luo Y; Yang M; Wen Z; Hu J; Lin F; Han M; Yin T; Yang R; Lin H; Qi J; Yang Y Bioorg Med Chem Lett; 2022 Feb; 57():128503. PubMed ID: 34922028 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors. Plyasova AA; Berrino E; Khan II; Veselovsky AV; Pokrovsky VS; Angeli A; Ferraroni M; Supuran CT; Pokrovskaya MV; Alexandrova SS; Gladilina YA; Sokolov NN; Hilal A; Carta F; Zhdanov DD J Med Chem; 2021 Aug; 64(15):11432-11444. PubMed ID: 34283610 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors. Luo Y; Zhang S; Qiu KM; Liu ZJ; Yang YS; Fu J; Zhong WQ; Zhu HL Bioorg Med Chem Lett; 2013 Feb; 23(4):1091-5. PubMed ID: 23312949 [TBL] [Abstract][Full Text] [Related]
20. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway. Chen J; Wang T; Xu S; Zhang P; Lin A; Wu L; Yao H; Xie W; Zhu Z; Xu J Eur J Med Chem; 2017 Jul; 135():414-423. PubMed ID: 28463784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]